Search Result |
Top |
| Entry | Name | Description | Category | Pathway | Gene |
|---|---|---|---|---|---|
| H00157 | Hyperlipoproteinemia, type V | ... disorder characterized by an increase of chylomicrons and VLDL and a decrease of LDL and HDL in the plasma after a fast. It has been reported that mutations in APOA5 cause type V hyperlipoproteinemia. | Inherited metabolic disorder | APOA5 [HSA:116519] [KO:K09025] | |
| H01635 | Hyperlipidemia | Dyslipidemia is a condition characterized by either an increase or decrease in concentration of lipids in the blood. Hyperlipidemia, which refers to an increase in cholesterol, triglyceride (TG), or both ... | Endocrine and metabolic disease |
(Hyperlipoproteinemia type 1) APOC2 [HSA:344] [KO:K22287] (Hyperlipoproteinemia type 1,2) LPL [HSA:4023] [KO:K01059] (Hyperlipoproteinemia type 2) LDLR [HSA:3949] [KO:K12473] (Hyperlipoproteinemia type 5) APOA5 [HSA:116519] [KO:K09025] |
|
| H01637 | Hypertriglyceridemia | Hypertriglyceridemia (HTG) is a condition with fasting triglyceride (TG) levels in blood continuing to rise. HTG generally refers to an increase of plasma triglyceride (TG) concentrations above the 95th ... | Endocrine and metabolic disease |
(HYTG1) APOA5 [HSA:116519] [KO:K09025] (HYTG2) CREB3L3 [HSA:84699] [KO:K09048] |
|
| H01784 | Primary hyperchylomicronemia | Primary hyperchylomicronemia is characterized by a marked hypertriglyceridemia due to the accumulation of chylomicron. The main clinical symptoms of this disorder are a huge increase in plasma triglyceride ... | Inherited metabolic disorder |
LPL [HSA:4023] [KO:K01059] APOC2 [HSA:344] [KO:K22287] GPIHBP1 [HSA:338328] [KO:K20001] LMF1 [HSA:64788] [KO:K23555] APOA5 [HSA:116519] [KO:K09025] |
| [ KEGG | DISEASE | DRUG | MEDICUS ] |